Document is current
Any future updates will be listed below
-
Authors
Kreuter, Michael https://orcid.org/0000-0003-4402-2159
Picker, Nils
Schwarzkopf, Larissa
Baumann, Severin
Cerani, Agustin
Postema, Roelien
Maywald, Ulf
Dittmar, Axel
Langley, Jonathan
Patel, Haridarshan
-
Funding
Funding for this research was provided by:
Galapagos NV
- License Information
-
More Information
Article History
Received: 5 October 2021
Accepted: 6 March 2022
First Online: 19 March 2022
Declarations
:
: We performed a retrospective analysis of anonymized data. For this type of study, there is no requirement for ethical approval and consent to participate according to the German Guidelines for Secondary Data Analysis.
: Not applicable.
: MK, or his institution, has received grants from Boehringer Ingelheim and Roche and remuneration for consultation by Boehringer Ingelheim, Galapagos NV, and Roche. NP and SB are employees of Ingress-Health, AD is an employee of IPAM; the work of Ingress-Health and IPAM in this study was funded by Galapagos NV. LS received consultation fees from Galapagos NV in relation to this study. UM is an employee of AOK PLUS. AC, HP, and RP are employees of Galapagos NV. JL is an employee and holds shares and warrants at Galapagos NV.
